Clinical Trial Update: Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether intravenous immunoglobulins can prevent BK virus infection in kidney transplant recipients, stratified by BKV genotype-specific…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection
• Bk Virus Nephropathy

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED